Curis
CRIS
#11244
Rank
HK$11.41 M
Marketcap
HK$4.71
Share price
9.39%
Change (1 day)
-59.34%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): -HK$112.35

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$111.54. In 2025 the company made an earnings per share (EPS) of -HK$186.77 an increase over its 2024 EPS that were of -HK$1,103.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$112.35-39.85%
2025-HK$186.77-83.07%
2024-HK$1,103-22.15%
2023-HK$1,417-26.17%
2022-HK$1,91922.3%
2021-HK$1,569-25.37%
2020-HK$2,102-30.93%
2019-HK$3,044-2.02%
2018-HK$3,106
2016-HK$7,060-10%
2015-HK$7,844138.1%
2014-HK$3,29540%
2013-HK$2,353-25%
2012-HK$3,13866.67%
2011-HK$1,883

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.61-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.82-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$25.89-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$34.12-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$24.94-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$26.98-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA